The role of ions in shaping the immune landscape of the

COVID-19 vaccines approved by WHO. EUA-Emergency use authorization

Schematic representation of the proposed mechanism of action of

PTX3 deficiency is associated with reduced inflammation and innate

Overview of failed and related ongoing phase II and III trials in

composition (mol%) of the bioactive polysaccharides fractions

Mechanisms mediating immunomodulation. MSCs and their derived

Summary of the molecular and cellular effects observed after

Global spread of COVID-19, showing the number of confirmed cases

PRISMA guidelines for article identification and selection

The MSC treatment doses, route of administration, treatment

Nicola VANNINI, Group Leader, PhD

First step trial selection by searching in the International